A Girls How To Guide 

Allergan, Teva claim top spots in GAAP vs. non-GAAP hall of shame: report

After expert panel vote, Endo's opioid Opana ER faces FDA restrictions—or withdrawal

AbbVie Granted Priority Review in Japan for its Investigational Regimen of Glecaprevir/Pibrentasvir

Concordia reports $1.3B loss after taking $1.1B write-off on pressured generics

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Adult and Pediatric Patients with Classical Hodgk

EPA Deputy Accused of Working With Monsanto to Kill Cancer Study

Zika Risk in Florida Extended Beyond Miami-Dade County

Scottish gov to stream extra £71m into general practice

The British Medical Association and the Royal College of Nursing warn immigration charge will cost N

Daiichi Sankyo Announces Large-scale Registry of Venous Thromboembolism (VTE) in Cancer Patients